Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Sabine Wrenger"'
Autor:
Tomoyuki Nakagiri, Fabio Ius, Ann-Kathrin Knöfel, Tobias Goecke, Patrick Zardo, Tobias Welte, Sabine Wrenger, Veronika Grau, Kokilavani Sivaraman, Axel Haverich, Sabina Janciauskiene
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-12 (2021)
Respiratory Research
Respiratory Research
Background α1-Antitrypsin (AAT) is an acute phase glycoprotein, a multifunctional protein with proteinase inhibitory, anti-inflammatory and cytoprotective properties. Both preclinical and clinical experiences show that the therapy with plasma purifi
Autor:
Pierre-Joseph Royer, Martine Reynaud-Gaubert, Antoine Magnan, Antoine Roux, Joanna Chorostowska-Wynimko, Christine S. Falk, Sabina Janciauskiene, Tobias Welte, Adrien Tissot, Jan Fuge, Sabine Wrenger
Publikováno v:
Journal of Inflammation Research. 13:1021-1028
Cumulating reports suggest that acute phase proteins (APPs) have diagnostic and prognostic value in different clinical conditions. Among others, APPs are proposed to serve as markers that help to control the outcome of transplant recipients. Here, we
Autor:
David S. DeLuca, Tobias Welte, Beatriz Martinez-Delgado, Sabina Janciauskiene, Bin Liu, Sabine Wrenger, Anna R. Gründing
Publikováno v:
Lung cancer.
Autor:
Jan Fuge, Tobias Welte, Pierre-Joseph Royer, Antoine Roux, Sabina Janciauskiene, Joanna Chorostowska, Adrien Tissot, Sabine Wrenger, Huiyuan Zhu, Antoine Magnan, Martine Reynaud-Gaubert
Publikováno v:
Transplantation.
In lung transplantation (Lu-Tx) long-term outcomes still remain poor compared to those of other types of solid organ transplantations. The main problem is the development of chronic lung allograft dysfunction (CLAD). The exact physiopathology of CLAD
Autor:
Nupur Aggarwal, Beatriz Martinez-Delgado, T. Yevsa, I. Hochnadel, Sabine Wrenger, Sabina Janciauskiene, Tobias Welte, Jan Stolk
Publikováno v:
Respiratory Medicine, 148, 60-62. W B SAUNDERS CO LTD
Human blood monocytes are divided into populations based on the differential expression of CD14 and CD16 receptors: CD14 (+) CD16(classical), CD14 (+) CD16 (+) (intermediate), and CD14(-)CD16(+) (non-classical). Given their functional differences and
Autor:
Sabina Janciauskiene, Sabine Wrenger, Stephan Immenschuh, Beata Olejnicka, Timm Greulich, Tobias Welte, Joanna Chorostowska-Wynimko
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Frontiers in Pharmacology
Frontiers in Pharmacology
Neutrophils are the predominant immune cells in human blood possessing heterogeneity, plasticity and functional diversity. The activation and recruitment of neutrophils into inflamed tissue in response to stimuli are tightly regulated processes. Alph
Autor:
Angelia D. Lockett, Samuel Kimani, Godfrey Ddungu, Sabine Wrenger, Rubin M. Tuder, Sabina Janciauskiene, Irina Petrache
Publikováno v:
American Journal of Respiratory Cell and Molecular Biology. 49:143-150
α1-Antitrypsin (A1AT) is an acute-phase reactant, but also a major protective factor against the development of chronic obstructive pulmonary disease, a complex disease with sustained chronic inflammation. The lung-protective effects of A1AT have be
Autor:
Sabine Wrenger, Ute Bank, Siegfried Ansorge, Ingrid Wiswedel, Uwe Lendeckel, Thilo Kähne, Robert Vetter, Klaus Neubert, Anja Thielitz, Dirk Reinhold, Jürgen Faust, Christos C. Zouboulis, Roland Hartig, Martin Helmuth, Harald Gollnick
Publikováno v:
Journal of Investigative Dermatology. 127:1042-1051
Acne is a chronic disease hallmarked by sebaceous hyperplasia, follicular hyperkeratosis, and inflammation. Parallel targeting of these factors is required to treat acne effectively. Inhibitors of dipeptidyl peptidase IV (DP IV) and aminopeptidase N
Autor:
Annegret Gerber, Vera Preller, Sabine Wrenger, Janine Tadje, Didier Marguet, Klaus Neubert, Uwe Lendeckel, Burkhart Schraven, Siegfried Ansorge, Jürgen Faust, Mauro Togni, Stefan Brocke, Christoph Röcken, Dirk Reinhold, Roland Martin
Publikováno v:
Journal of Immunology
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2007, 178 (7), pp.4632-40
Journal of Immunology, 2007, 178 (7), pp.4632-40
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2007, 178 (7), pp.4632-40
Journal of Immunology, 2007, 178 (7), pp.4632-40
The T cell marker CD26/dipeptidyl peptidase (DP) IV is associated with an effector phenotype and markedly elevated in the human CNS disorder multiple sclerosis. However, little is known about the in vivo role of CD26/DP IV in health and disease, and
Autor:
Uwe Lendeckel, Torsten Hoffmann, Dirk Reinhold, Thilo Kähne, Klaus Neubert, Daniel Friedrich, Anja Thielitz, Roland Hartig, Jürgen Faust, Sabine Wrenger
Publikováno v:
Journal of Leukocyte Biology. 80:621-629
The ectoenzyme dipeptidyl peptidase IV (DP IV; CD26) was shown to play a crucial role in T cell activation. Several compounds inhibiting DP IV-like activity are currently under investigation for the treatment of Type 2 diabetes, rheumatoid arthritis,